V5D1 Stock Overview Operates as an integrated cannabis company. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Delta 9 Cannabis Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Delta 9 Cannabis Historical stock prices Current Share Price US$0.0092 52 Week High US$0.088 52 Week Low US$0.005 Beta 1.31 1 Month Change 0% 3 Month Change 15.00% 1 Year Change -69.13% 3 Year Change -95.89% 5 Year Change -98.65% Change since IPO -98.79%
Recent News & Updates
FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN). Jul 16
First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023) May 17
Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024 Apr 20
Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022) Apr 02
New major risk - Shareholder dilution Feb 14
New major risk - Negative shareholders equity Nov 17 See more updates
FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN). Jul 16
First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023) May 17
Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024 Apr 20
Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022) Apr 02
New major risk - Shareholder dilution Feb 14
New major risk - Negative shareholders equity Nov 17
Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022) Nov 17
Delta 9 Cannabis Inc. to Report Q3, 2023 Results on Nov 14, 2023 Oct 31
New major risk - Shareholder dilution Aug 24
Second quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2022) Aug 15
Delta 9 Cannabis Inc. to Report Q2, 2023 Results on Aug 14, 2023 Jul 28
Co-Founder recently sold €68k worth of stock Jun 23
First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.037 loss in 1Q 2022) May 17 Delta 9 Cannabis Inc. to Report Q1, 2023 Results on May 15, 2023 Delta 9 Cannabis Inc. to Report Q4, 2022 Results on Mar 31, 2023
Delta 9 Cannabis Inc. Announces Changes to Board of Directors Dec 20
Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.011 loss in 3Q 2021) Nov 17
Insufficient new directors Nov 16
Delta 9 Cannabis Inc. Provides Earnings Guidance for the Quarter and Nine Months Ended September 30, 2022 Nov 12
Delta 9 Cannabis Inc. to Report Q3, 2022 Results on Nov 14, 2022 Nov 11
Delta 9 Cannabis Inc. (TSX:DN) acquired All or Substantially All Assets from 10552763 Canada Corp. Sep 08
Second quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.014 loss in 2Q 2021) Aug 17
Delta 9 Cannabis Inc. (TSX:DN) entered into an asset purchase agreement to acquire all or Substantially all assets of 10552763 Canada Corp. for CAD 3.25 million. Aug 16 Joanne Duhoux-Defehr Resigns from Board of Directors of Delta 9 Cannabis Inc Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million. Jun 17
Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million. Jun 11
First quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.042 loss in 1Q 2021) May 17 Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Months Period Ended March 31, 2022
Delta 9 Cannabis Inc., Annual General Meeting, Jun 29, 2022 May 02
Insufficient new directors Apr 27
Full year 2021 earnings released: CA$0.11 loss per share (vs CA$0.072 loss in FY 2020) Apr 01 Delta 9 Cannabis Inc. announced that it has received CAD 9.6 million in funding from Sundial Growers Inc. Apr 01
Delta 9 Cannabis Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Year Ending December 31, 2021 Jan 13
Insufficient new directors Dec 06
Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.07 loss in 3Q 2020) Nov 17
Independent Director recently sold €88k worth of stock Oct 28
Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 2Q 2020) Aug 18
Delta 9 Cannabis Inc. Announces Health Canada Approval for Perimeter Expansion and Vault Area Aug 12
Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three-Month and Six-Month Period Ending June 30, 2021 Jun 24
Co-Founder recently sold €93k worth of stock May 29
Co-Founder recently sold €78k worth of stock May 22
First quarter 2021 earnings released: EPS CA$0.04 (vs CA$0.023 in 1Q 2020) May 18
Delta 9 Cannabis Inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2021 May 07
Full year 2020 earnings released: CA$0.07 loss per share (vs CA$0.16 profit in FY 2019) Apr 02
Delta 9 Cannabis Inc. Provides Update on Strategic Cooperation Agreement with F1NE Cannabis Cultivation LTD Mar 03
Delta 9 Cannabis Inc. Launches Province Wide Delivery in Saskatchewan and Reserve Online in Alberta Feb 27
New 90-day high: €0.46 Feb 12
Delta 9 Cannabis Inc. to Report Q4, 2020 Results on Mar 30, 2021 Feb 11
Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner Feb 05
New 90-day high: €0.38 Jan 26
Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner Dec 24
Co-Founder recently bought €62k worth of stock Dec 24
New 90-day low: €0.29 Dec 23
Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 5.000001 million. Dec 23
Delta 9 Partners with Emterra Environmental to Create Sustainable Recycling and Landfill Diversion Program for Canadian Cannabis Industry Dec 16
Delta 9 Cannabis Inc. Completes Final Services Milestone Under an Agreement with Prairie Craft Canopy Dec 12
Delta 9 Cannabis Inc. Develops Proprietary Decontamination Technology to Help Fight COVID-19 Pandemic Nov 26
Delta 9 Launches Click & Collect and Same Day Delivery Service in Thompson & Brandon, Manitoba Nov 25
Delta 9 Cannabis Inc. Completes Final Services Milestone Under an Agreement with Ahahswinis Green Investments Ltd Nov 20
Third quarter 2020 earnings released: CA$0.07 loss per share Nov 13
Delta 9 Cannabis Inc. to Report Q3, 2020 Results on Nov 12, 2020 Oct 30
Delta 9 Cannabis Inc. Enters into Strategic Cooperation Agreement with Paradise Cannabis Ltd Oct 27
Delta 9 Cannabis Inc. Achieves Milestone in Agreement with Micro Cultivation Partner Oct 14
Delta 9 Cannabis Inc. to Report Q2, 2019 Results on Aug 27, 2019 Oct 01
Delta 9 Cannabis Inc. Achieves Milestone in Agreement with Micro Cultivation Partner Sep 30
New 90-day high - €0.36 Aug 11
Delta 9 Cannabis Inc. to Report Q2, 2020 Results on Aug 14, 2020 Jul 31 Shareholder Returns V5D1 DE Pharmaceuticals DE Market 7D 0% 1.4% 0.5% 1Y -69.1% -16.3% 7.2%
See full shareholder returns
Return vs Market: V5D1 underperformed the German Market which returned 4.2% over the past year.
Price Volatility Is V5D1's price volatile compared to industry and market? V5D1 volatility V5D1 Average Weekly Movement n/a Pharmaceuticals Industry Average Movement 5.5% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.5% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: V5D1's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine V5D1's volatility change over the past year.
About the Company Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products.
Show more Delta 9 Cannabis Inc. Fundamentals Summary How do Delta 9 Cannabis's earnings and revenue compare to its market cap? V5D1 fundamental statistics Market cap €2.50m Earnings (TTM ) -€13.06m Revenue (TTM ) €47.09m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) V5D1 income statement (TTM ) Revenue CA$70.65m Cost of Revenue CA$58.10m Gross Profit CA$12.55m Other Expenses CA$32.15m Earnings -CA$19.60m
Last Reported Earnings
Mar 31, 2024
Earnings per share (EPS) -0.054 Gross Margin 17.77% Net Profit Margin -27.74% Debt/Equity Ratio -447.3%
How did V5D1 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/09/11 07:18 End of Day Share Price 2024/07/16 00:00 Earnings 2024/03/31 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Delta 9 Cannabis Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Kimberly Thompson-Hedlin Canaccord Genuity Siddharth Rajeev Fundamental Research Corp. Venkata Velagapudi Research Capital Corporation
Show 0 more analysts 
